SCHIZOPHRENIA FORMULA 2113- schizophrenia formula liquid United States - English - NLM (National Library of Medicine)

schizophrenia formula 2113- schizophrenia formula liquid

professional complementary health formulas - so-lo-tzu 3x hsiang-jih-kuei-hua-pan 3x, 6x ji-qing-hua 4x wu-tsei-ku 30x - for the temporary relief of confusion, memory loss, disorientation, anxiousness, feelings of anger or fear, or mood swings.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Abilify Maintena European Union - English - EMA (European Medicines Agency)

abilify maintena

otsuka pharmaceutical netherlands b.v. - aripiprazole - schizophrenia - psycholeptics - maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Adasuve European Union - English - EMA (European Medicines Agency)

adasuve

ferrer internacional s.a. - loxapine - schizophrenia; bipolar disorder - nervous system - adasuve is indicated for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder. patients should receive regular treatment immediately after control of acute agitation symptoms.

Invega European Union - English - EMA (European Medicines Agency)

invega

janssen-cilag international nv - paliperidone - schizophrenia; psychotic disorders - psycholeptics - invega is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older.invega is indicated for the treatment of schizoaffective disorder in adults.

Latuda European Union - English - EMA (European Medicines Agency)

latuda

aziende chimiche riunite angelini francesco s.p.a. - lurasidone - schizophrenia - psycholeptics - treatment of schizophrenia in adults aged 18 years and over.

Xeplion European Union - English - EMA (European Medicines Agency)

xeplion

janssen-cilag international n.v. - paliperidone palmitate - schizophrenia - psycholeptics - xeplion is indicated for maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone.in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

Olanzapine Mylan European Union - English - EMA (European Medicines Agency)

olanzapine mylan

mylan pharmaceuticals limited - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode.in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Zalasta European Union - English - EMA (European Medicines Agency)

zalasta

krka - olanzapine - schizophrenia; bipolar disorder - psycholeptics - olanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode.in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Olanzapine Glenmark European Union - English - EMA (European Medicines Agency)

olanzapine glenmark

glenmark arzneimittel gmbh - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode. in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.